tradingkey.logo

tradingkey.logo
怜玢


AngioDynamics Inc

ANGO
りォッチリストに远加
10.770USD
-0.260-2.36%
終倀 05/15, 16:00ET15分遅れの株䟡
448.92M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 AngioDynamics Inc 䌁業名

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

AngioDynamics Incの䌁業情報


䌁業コヌドANGO
䌚瀟名AngioDynamics Inc
䞊堎日May 27, 2004
最高経営責任者「CEO」Clemmer (James C)
埓業員数675
蚌刞皮類Ordinary Share
決算期末May 27
本瀟所圚地14 Plaza Drive
郜垂LATHAM
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号12110
電話番号15187981215
りェブサむトhttps://www.angiodynamics.com/
䌁業コヌドANGO
䞊堎日May 27, 2004
最高経営責任者「CEO」Clemmer (James C)

AngioDynamics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-35.34%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Chad T. Campbell
Mr. Chad T. Campbell
Senior Vice President, General Manager - Global Oncology and Vascular Access
Senior Vice President, General Manager - Global Oncology and Vascular Access
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-35.34%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2026Q3
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
67.28M
85.79%
International
11.14M
14.21%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
BlackRock Institutional Trust Company, N.A.
7.81%
Point72 Asset Management, L.P.
6.84%
Systematic Financial Management, L.P.
6.06%
Kotler (Kevin)
5.86%
Vanguard Capital Management, LLC
4.18%
他の
69.25%
株䞻統蚈
株䞻統蚈
比率
BlackRock Institutional Trust Company, N.A.
7.81%
Point72 Asset Management, L.P.
6.84%
Systematic Financial Management, L.P.
6.06%
Kotler (Kevin)
5.86%
Vanguard Capital Management, LLC
4.18%
他の
69.25%
皮類
株䞻統蚈
比率
Investment Advisor
39.21%
Investment Advisor/Hedge Fund
27.36%
Hedge Fund
19.75%
Individual Investor
12.28%
Venture Capital
3.42%
Research Firm
2.31%
Pension Fund
1.68%
Bank and Trust
0.26%
Insurance Company
0.03%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
321
38.82M
93.94%
-7.22M
2025Q4
311
40.19M
106.71%
-10.46K
2025Q3
344
40.20M
109.06%
+1.51M
2025Q2
370
37.97M
110.38%
+1.85M
2025Q1
372
36.50M
106.59%
-6.63M
2024Q4
361
34.34M
98.76%
+1.35M
2024Q3
371
33.44M
109.60%
-216.03K
2024Q2
370
33.66M
118.59%
-3.23M
2024Q1
368
36.03M
115.74%
-10.10M
2023Q4
378
37.01M
114.23%
+355.36K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
BlackRock Institutional Trust Company, N.A.
3.23M
7.83%
+322.43K
+11.11%
Dec 31, 2025
Point72 Asset Management, L.P.
2.83M
6.86%
+266.70K
+10.42%
Dec 31, 2025
Systematic Financial Management, L.P.
2.50M
6.08%
-65.64K
-2.55%
Dec 31, 2025
Kotler (Kevin)
2.42M
5.88%
+2.42M
--
Jan 06, 2026
Broadfin Holdings, LLC
1.71M
4.16%
+1.71M
--
Dec 31, 2025
Armistice Capital LLC
1.70M
4.12%
+64.00K
+3.91%
Dec 31, 2025
Royce Investment Partners
1.27M
3.08%
+272.09K
+27.34%
Dec 31, 2025
Weber Capital Management, LLC
1.40M
3.4%
+1.40M
--
Dec 31, 2025
Bastion Asset Management Inc.
1.12M
2.71%
-145.82K
-11.54%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.63%
Vanguard US Multifactor ETF
0.15%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
詳现を芋る
State Street SPDR S&P Health Care Equipment ETF
比率0.79%
Invesco NASDAQ Future Gen 200 ETF
比率0.63%
Vanguard US Multifactor ETF
比率0.15%
iShares Micro-Cap ETF
比率0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0.07%
Fidelity Enhanced Small Cap ETF
比率0.06%
Avantis US Small Cap Equity ETF
比率0.06%
Invesco RAFI US 1500 Small-Mid ETF
比率0.04%
iShares Russell 2000 Value ETF
比率0.02%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™